Patient Guide: TRE-515 in combination with radioligand therapy for PSMA-positive metastatic castration-resistant prostate cancer

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at multiple participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTTRE-515
Status: ANNOUNCED
Condition: Metastatic castration-resistant prostate cancer
Phase: PHASE1

Loading interactive enrollment tools...

The full interactive experience will load momentarily